Australia, April 18 -- Janssen Pharmaceutica NV, owns the trademark (2614953) for 'INTREPTYDE' till Nov. 27, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for human use.]
Type of Mark: Word
Date of Acceptance: Jan. 28
Registration Advertised: April 17
For further details contact Actelion Pharmaceuticals Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2614953.
Disclaimer: Curated by HT Syndication.
